Michael Behringer1,2,3, Stephanie Nowak4, Jannik Leyendecker4, Joachim Mester4. 1. German Research Center of Elite Sport - momentum, German Sport University Cologne, Cologne, Germany. behringer@dshs-koeln.de. 2. Institute of Biomechanics and Orthopaedics, German Sport University Cologne, Cologne, Germany. behringer@dshs-koeln.de. 3. Institute of Cardiology and Sports Medicine, German Sport University Cologne, Cologne, Germany. behringer@dshs-koeln.de. 4. German Research Center of Elite Sport - momentum, German Sport University Cologne, Cologne, Germany.
Abstract
PURPOSE: Previous data indicate that a strong sensory input from orally administered TRPV1 and TRPA1 activators alleviates muscle cramps in foot muscles by reducing the α-motor neuron hyperexcitability. We investigated if TRP activators increase the cramp threshold frequency of the medial gastrocnemius. METHODS: We randomly assigned 22 healthy male participants to anintervention (IG) and a control group (CG). While participants of the IG ingested a mixture of TRPV1 and TRPA1 activators, the CG received a placebo. We tested the cramp threshold frequency (CTF), the cramp intensity (EMG activity), and the perceived pain of electrically induced muscle cramps before (pre), and 15 min, 4, 8, and 24 h after either treatment. We further measured the maximal isometric force of knee extensors at pre, 4, and 24 h to assess potential side-effects on the force output. RESULTS: When we included all measurement time points, no group-by-time interaction was observed for the CTF. However, when only pre and 15 min values were incorporated, a significant interaction, with a slightly greater CTF increase in IG (3.1 ± 1.5) compared to the CG (2.0 ± 1.5), was observed. No significant group by time interaction was found for the cramp intensity, the perceived pain, and the maximal isometric force. CONCLUSION: Our data indicate that orally administered TRPV1 and TRPA1 activators exert a small short-term effect on the CTF, but not on the other parameters tested. Future studies need to investigate whether such small CTF increments are sufficient to prevent exercise-associated muscle cramps.
RCT Entities:
PURPOSE: Previous data indicate that a strong sensory input from orally administered TRPV1 and TRPA1 activators alleviates muscle cramps in foot muscles by reducing the α-motor neuron hyperexcitability. We investigated if TRP activators increase the cramp threshold frequency of the medial gastrocnemius. METHODS: We randomly assigned 22 healthy male participants to an intervention (IG) and a control group (CG). While participants of the IG ingested a mixture of TRPV1 and TRPA1 activators, the CG received a placebo. We tested the cramp threshold frequency (CTF), the cramp intensity (EMG activity), and the perceived pain of electrically induced muscle cramps before (pre), and 15 min, 4, 8, and 24 h after either treatment. We further measured the maximal isometric force of knee extensors at pre, 4, and 24 h to assess potential side-effects on the force output. RESULTS: When we included all measurement time points, no group-by-time interaction was observed for the CTF. However, when only pre and 15 min values were incorporated, a significant interaction, with a slightly greater CTF increase in IG (3.1 ± 1.5) compared to the CG (2.0 ± 1.5), was observed. No significant group by time interaction was found for the cramp intensity, the perceived pain, and the maximal isometric force. CONCLUSION: Our data indicate that orally administered TRPV1 and TRPA1 activators exert a small short-term effect on the CTF, but not on the other parameters tested. Future studies need to investigate whether such small CTF increments are sufficient to prevent exercise-associated muscle cramps.
Entities:
Keywords:
Muscle cramp; Muscle, skeletal; TRPA1 protein; TRPV1 protein
Authors: Daniel H Craighead; Sean W Shank; Jinger S Gottschall; Dennis H Passe; Bob Murray; Lacy M Alexander; W Larry Kenney Journal: Muscle Nerve Date: 2017-05-09 Impact factor: 3.217
Authors: Kevin C Miller; Gary W Mack; Kenneth L Knight; J Ty Hopkins; David O Draper; Paul J Fields; Iain Hunter Journal: Med Sci Sports Exerc Date: 2010-05 Impact factor: 5.411
Authors: Kevin C Miller; Brendon P McDermott; Susan W Yeargin; Aidan Fiol; Martin P Schwellnus Journal: J Athl Train Date: 2021-06-29 Impact factor: 2.860